Ali Murat Kahveci and Veysel Tahan (2019) “Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies ”, Turkish Journal of Gastroenterology, 27(1), pp. 89–90. Available at: https://turkjgastroenterol.avesjournals.com/index.php/tjg/article/view/3228 (Accessed: 8 July 2025).